20 stocks in focus today: Signature Global, IndusInd Bank, pharma, railway and power counters

From Signature Global’s ₹920-crore construction contracts to IndusInd Bank’s RBI approval for a stockbroking subsidiary, today’s watchlist features major updates across real estate, banking, pharma, railways and clean energy, with NBCC, RITES and Emcure Pharma also in focus.